Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 14, 2012Hepatology

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent

View Full Paper
Ask AI
Bookmark
Share

Authors

TATomonori AoyamaJuntendo UniversityYPYong‐Han PaikSamsung (South Korea)SWSumio WatanabeThe Japanese Society of Gastroenterological Surgery

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Aoyama et al. (2012) studied this question.

synapsesocial.com/papers/69fd2bf9f8347cff7f5d0bd3https://doi.org/10.1002/hep.25938
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-Ay mice #2009 · 52 citations
  2. 2Liver fibrosis2005 · 1,478 citations
  3. 3Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.1989 · 401 citations
  4. 4A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations2004 · 251 citations
  5. 5Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells2008 · 91 citations